AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial

On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.

This IDE clinical trial evaluates Abbott’s Coronary IVL System, an innovative technology that uses sound pressure waves to break up severe calcium deposits in coronary arteries before stent placement. The system represents a promising advancement in the treatment of complex coronary artery disease.

A sincere thank you to the entire team for their dedication and enthusiasm in supporting this important research initiative.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Advancing T1D Science: New TRI Publications

Researchers at the AdventHealth Translational Research Institute continue to drive meaningful progress in Type 1 diabetes—work that is being recognized not just in Central Florida, but throughout the...